Hematología y Hemoterapia

Resultados: 466
Tipo Título / Nombre Autor(es) Año
Do multiple myeloma R/R patients benefit from early treatment at biological relapse? preliminary results of a spanish obsrvational prospective registry Fernández Delarrea C, Escalante F, Alegre A, Bergua JM, Martínez Chamorro C, López A, et al 2016
An ex vivo native environment precision medicine test shows high clinical correlation with responses to first line acute myeloid leukemia treatment Montesinos P, Ballesteros J, Martínez Cuadron D, Martínez Lopez J, Serrano J, Pérez de Oteyza J, et al 2016
Lack of prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative, b-cell precursor all treated according to MRD oriented protocols Ribera JM, Morgades M, Ciudad J, Montesinos P, Tormo M, González Campos J, et al 2016
Preliminary results of the flugaza trial: a phase iii randomized, open label study comparing azacytidine versus fludarabine and cytarabine (fluga scheme) in elderly patients with newly diagnosed acute myeloid leukemia Vives S, Martínez-Sánchez MD, Bergua J, Algarra L, Herrera Pilar MD, Tormo M, et al 2016
Sequential vs alternating administration of VMP and Rd in elderly patients with newly diagnosed MM Mateos MV, Martínez-López J, Hernández MT, Ocio EM, Rosiñol L, Martínez R, et al 2016
Minimal residual disease monitoring and immune profiling using second generation flow cytometry in elderly multiple myeloma Paiva B, Cedena MT, Puig N, Arana P, Vidriales MB, Cordon L, et al 2016
Real-life management of primary immune thrombocytopenia (ITP) in adult patients and adherence to practice guidelines Lozano ML, Revilla N, González-López TJ, Novelli S, González-Porras JR, Sánchez-Gonzalez B, et al 2016
Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disorders Bastida JM, Del Rey M, Lozano ML, Sarasquete ME, Benito R, Fontecha ME, et al 2016
Natural killer cell immunosenescence in acute myeloid leukaemia patients: new targets for immunotherapeutic strategies? Sánchez-Correa B, Campos C, Pera A, Bergua JM, Arcos MJ, Bañas H, et al 2016
Seguridad Transfusional y efectos adversos: protocolos y actuaciones Ibáñez Espacio F, Lanzas Merino F 2015